HomeCompareFLIA vs MRK

FLIA vs MRK: Dividend Comparison 2026

FLIA yields 2.61% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $7.2K in total portfolio value
10 years
FLIA
FLIA
● Live price
2.61%
Share price
$20.26
Annual div
$0.53
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$309.26
Full FLIA calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — FLIA vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFLIAMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FLIA + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FLIA pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FLIA
Annual income on $10K today (after 15% tax)
$222.09/yr
After 10yr DRIP, annual income (after tax)
$262.87/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $544.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FLIA + MRK for your $10,000?

FLIA: 50%MRK: 50%
100% MRK50/50100% FLIA
Portfolio after 10yr
$27.2K
Annual income
$629.78/yr
Blended yield
2.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FLIA
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FLIA buys
0
MRK buys
0
No recent congressional trades found for FLIA or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFLIAMRK
Forward yield2.61%3.25%
Annual dividend / share$0.53$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$23.6K$30.7K
Annual income after 10y$309.26$950.29
Total dividends collected$2.9K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FLIA vs MRK ($10,000, DRIP)

YearFLIA PortfolioFLIA Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,961$261.28$11,192$351.54$231.00MRK
2$11,996$267.66$12,524$392.70$528.00MRK
3$13,110$273.77$14,015$438.65$905.00MRK
4$14,307$279.61$15,682$489.96$1.4KMRK
5$15,594$285.18$17,547$547.23$2.0KMRK
6$16,976$290.49$19,632$611.16$2.7KMRK
7$18,460$295.55$21,963$682.53$3.5KMRK
8$20,052$300.36$24,571$762.18$4.5KMRK
9$21,761$304.93$27,486$851.08$5.7KMRK
10$23,593$309.26$30,745$950.29$7.2KMRK

FLIA vs MRK: Complete Analysis 2026

FLIAStock

The fund seeks to maximize total investment return, consisting of a combination of interest income and capital appreciation, by investing primarily in investment grade fixed or floating-rate bonds issued by governments, government agencies and governmental-related or corporate issuers located outside the U.S. The investment manager seeks to hedge substantially all of the fund's foreign currency exposure using currency-related derivatives.

Full FLIA Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this FLIA vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FLIA vs SCHDFLIA vs JEPIFLIA vs OFLIA vs KOFLIA vs MAINFLIA vs JNJFLIA vs ABBVFLIA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.